Position in ABBV
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$4,265,298
+$591,240 QoQ
Shares Held
16,950
+0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
3.05%
of 13F equity value
Holder Rank
#1,420
of 4,153 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VIEWPOINT INVESTMENT PARTNERS CORP holds $4,798,146 across 2 Drug Manufacturers - General names. ABBV ranks #1 (88.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
16,950 | $4,265,298 | |
| 2 | NVS |
Novartis AG
|
3,400 | $532,848 |
All Filings in ABBV
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,265,298 | 16,950 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $3,674,058 | 16,893 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $3,875,875 | 16,963 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $4,027,175 | 17,393 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $3,228,488 | 17,393 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $1,308,033 | 6,243 | Shares | Sole | 2025-04-16 | |
| No filing history on record for this holder in this stock. | ||||||